ARGNF
PINK argenx SE$936.00 ↓ -15.43 (-1.62%) Trading Down from the previous close of $951.43, and at the day’s high of $936.00
- YTD change
- -1.62%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+97.00 (+11.56%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 1.6% away from all-time highs of $951.43
- ARGNF is down 2% since the beginning of the year
- ARGNF is down 2% over the past 12 months
- ARGNF is down 2% over the past 1 month
- 0% of all ARGNF investors are betting against ARGNF
ARGNF reads n/a: the 12-month move is +12.3%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -1.62%
- vs 8-day SMA
- N/A
No alerts for ARGNF in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.